EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Induced Pluripotent Stem Cell‐Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti‐Inflammatory Immunomodulatory Mechanism

Daniel Levy, Sanaz Nourmohammadi Abadchi, Niloufar Shababi, Mohsen Rouhani Ravari, Nicholas H Pirolli, Cade Bergeron, Angel Obiorah, Farzad Mokhtari-Esbuie, Shayan Gheshlaghi, John M Abraham, Ian M Smith, Emily H Powsner und 3 weitere

Advanced Healthcare Materials · 2023-10 · 12 (26)

DOI: 10.1002/adhm.202300879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.06.2023. Verfasst von Daniel Levy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Extracellular Vesicles, Diabetes Mellitus. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) derived from mesenchymal stem/stromal cells (MSCs) have recently been explored in clinical trials for treatment of diseases with complex pathophysiologies. However, production of MSC EVs is currently hampered by donor‐specific characteristics and limited ex vivo expansion capabilities before decreased potency, thus restricting their potential as a scalable and reproducible therapeutic. Induced pluripotent stem cells (iPSCs) represent a self‐renewing source for obtaining differentiated iPSC‐derived MSCs (iMSCs), circumventing both scalability and donor variability concerns for therapeutic EV production. Thus, it is initially sought to evaluate the therapeutic potential of iMSC EVs. Interestingly, while utilizing undifferentiated iPSC EVs as a control, it is found that their vascularization bioactivity is similar and their anti‐inflammatory bioactivity is superior to donor‐matched iMSC EVs in cell‐based assays. To supplement this initial in vitro bioactivity screen, a diabetic wound healing mouse model where both the pro‐vascularization and anti‐inflammatory activity of these EVs would be beneficial is employed. In this in vivo model, iPSC EVs more effectively mediate inflammation resolution within the wound bed. Combined with the lack of additional differentiation steps required for iMSC generation, these results support the use of undifferentiated iPSCs as a source for therapeutic EV production with respect to both scalability and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsExtracellular VesiclesDiabetes MellitusMiceAnimalsCell DifferentiationAnti-Inflammatory AgentsWound Healing

Stichwörter der Autor:innen

exosomesinduced pluripotent stem cell-mesenchymal stem/stromal cellsinduced pluripotent stem cellsinflammationwound healing

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.
  • Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA.
  • Program in Molecular and Cell Biology, University of Maryland, College Park, MD, 20742, USA.

ORCID-Profile: Steven M Jay

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • National Science Foundation
  • University of Maryland Foundation

Zitieren

APA

Levy, D., Abadchi, S. N., Shababi, N., Ravari, M. R., Pirolli, N. H., Bergeron, C., Obiorah, A., Mokhtari-Esbuie, F., Gheshlaghi, S., Abraham, J. M., Smith, I. M., Powsner, E. H., Solomon, T. J., Harmon, J. W., & Jay, S. M. (2023). Induced Pluripotent Stem Cell‐Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti‐Inflammatory Immunomodulatory Mechanism. Advanced Healthcare Materials, 12(26). https://doi.org/10.1002/adhm.202300879

Vancouver

Levy D, Abadchi SN, Shababi N, Ravari MR, Pirolli NH, Bergeron C, et al. Induced Pluripotent Stem Cell‐Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti‐Inflammatory Immunomodulatory Mechanism. Advanced Healthcare Materials. 2023;12(26). doi:10.1002/adhm.202300879

BibTeX
@article{Levy2023,
  author = {Levy, Daniel and Abadchi, Sanaz Nourmohammadi and Shababi, Niloufar and Ravari, Mohsen Rouhani and Pirolli, Nicholas H and Bergeron, Cade and Obiorah, Angel and Mokhtari-Esbuie, Farzad and Gheshlaghi, Shayan and Abraham, John M and Smith, Ian M and Powsner, Emily H and Solomon, Talia J and Harmon, John W and Jay, Steven M},
  title = {Induced Pluripotent Stem Cell‐Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti‐Inflammatory Immunomodulatory Mechanism},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {26},
  doi = {10.1002/adhm.202300879}
}
Kostenlos starten →